| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $52,654,240 ) (Continued on the next page) |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01DA051037 | 20/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT VCU | 001 | 6 | NIH | 3/17/2025 | $1,347,754 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE033842 | Connecting liquid-liquid phase separation with super-enhancers and key oncogene transcription in HNSCC | 001 | 2 | NIH | 5/9/2025 | $18,937 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE033842 | Connecting liquid-liquid phase separation with super-enhancers and key oncogene transcription in HNSCC | 000 | 2 | NIH | 3/10/2025 | $170,435 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32TR004362 | CTSA Predoctoral T32 at Virginia Commonwealth University | 000 | 2 | NIH | 12/7/2024 | $203,568 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM152058 | Ins and outs of the bioactive sphingolipid metabolite sphingosine-1-phosphate | 001 | 2 | NIH | 12/2/2024 | $349,313 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03CA270837 | Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening among Rural Screening Age-Eligible Adults | 003 | 3 | NIH | 2/12/2025 | $0 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03CA270837 | Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening among Rural Screening Age-Eligible Adults | 002 | 3 | NIH | 1/27/2025 | $89,340 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21AI178143 | Mechanisms and consequences of human papillomavirus 16 E2 regulation of host gene transcription | 000 | 2 | NIH | 11/27/2024 | $188,241 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA281207 | Targeting cancer cachexia drivers using antibody-based approaches | 001 | 2 | NIH | 6/5/2025 | $41,765 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA281207 | Targeting cancer cachexia drivers using antibody-based approaches | 000 | 2 | NIH | 11/19/2024 | $375,887 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32GM148403 | VCU Initiative for Maximizing Student Development Program (IMSD) | 001 | 3 | NIH | 4/25/2025 | $0 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32GM148403 | VCU Initiative for Maximizing Student Development Program (IMSD) | 000 | 3 | NIH | 1/24/2025 | $270,995 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277437 | Enhancing Tumor Cell Immunogenicity using Improved Molecules Targeting Chromatin Remodeling | 001 | 2 | NIH | 5/30/2025 | $18,133 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277437 | Enhancing Tumor Cell Immunogenicity using Improved Molecules Targeting Chromatin Remodeling | 000 | 2 | NIH | 11/14/2024 | $163,199 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL163101 | Protein S-Palmitoylation in the Heart: Function and Regulation in Health and Disease | 000 | 3 | NIH | 11/18/2024 | $373,062 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61AI179996 | Development of genetic tools for Orientia tsutsugamushi | 000 | 2 | NIH | 12/6/2024 | $261,247 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 000 | 2 | NIH | 5/16/2025 | $73,828 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG1CA287017 | Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) | 002 | 2 | NIH | 6/2/2025 | $80,606 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG1CA287017 | Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) | 001 | 2 | NIH | 4/3/2025 | $502,745 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG1CA287017 | Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) | 000 | 2 | NIH | 12/5/2024 | $725,460 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DE034063 | Decoding the glycome of oral Treponema denticola | 000 | 2 | NIH | 5/15/2025 | $490,511 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30DK143698 | Breaking Down Bones: Hepato-skeletal crosstalk in MASLD-associated fracture susceptibility | 000 | 1 | NIH | 6/12/2025 | $33,538 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 001 | 2 | NIH | 5/28/2025 | $564 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 000 | 2 | NIH | 4/10/2025 | $43,404 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL168133 | Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide | 000 | 3 | NIH | 3/11/2025 | $388,125 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 001 | 5 | NIH | 5/22/2025 | $47,095 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI078958 | Understanding Unique Aspects of Motility and Chemotaxis in Borrelia burgdorferi | 000 | 14 | NIH | 3/19/2025 | $473,229 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 000 | 5 | NIH | 3/17/2025 | $423,861 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA260819 | A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells | 001 | 5 | NIH | 5/1/2025 | $0 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA260819 | A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells | 002 | 5 | NIH | 5/22/2025 | $51,739 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA260819 | A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells | 000 | 5 | NIH | 3/3/2025 | $465,649 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21MH138949 | Studying normal and disease processes in brain with extracellular vesicles | 000 | 1 | NIH | 3/11/2025 | $271,688 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR082365 | Unraveling the Mechanism of Mechanotransduction in Hierarchical Collagen Fiber Formation | 001 | 3 | NIH | 5/15/2025 | $23,340 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR082365 | Unraveling the Mechanism of Mechanotransduction in Hierarchical Collagen Fiber Formation | 000 | 3 | NIH | 2/14/2025 | $300,078 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK137998 | An Integrated Lifestyle Intervention to Promote Cardiometabolic Health among Emerging Adult Women | 000 | 2 | NIH | 2/17/2025 | $279,450 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA290863 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC) | 000 | 1 | NIH | 1/31/2025 | $671,757 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01NS077675 | Mild traumatic brain injury alters interneuron structure and function | 002 | 12 | NIH | 4/16/2025 | $495,360 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AA020912 | 4/11 Neuroimmune and extracellular matrix interactions in alcohol consumption | 000 | 15 | NIH | 3/4/2025 | $384,244 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01FD006071 | Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal) | 003 | 5 | FDA | 6/9/2025 | $398,302 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI167857 | Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis | 000 | 4 | NIH | 1/28/2025 | $555,206 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH124981 | Developmental methylomics of autism spectrum disorder | 000 | 5 | NIH | 2/13/2025 | $585,546 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DE030667 | Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis | 001 | 5 | NIH | 5/6/2025 | $48,921 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DE030667 | Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis | 000 | 5 | NIH | 1/27/2025 | $440,286 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD018324 | The relationship between social needs and primary care use after enrollment in Virginia’s Medicaid expansion: The influence of sociocultural and built environments | 000 | 3 | NIH | 10/29/2024 | $42,911 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03AI180319 | Enzymology and Structure of Divergent Type 4 Pilus Extension ATPases | 000 | 2 | NIH | 11/25/2024 | $75,296 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K08HL155852 | Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy | 000 | 5 | NIH | 1/21/2025 | $148,052 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AG076481 | Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease | 001 | 4 | NIH | 5/28/2025 | $1,482,927 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM155045 | Dissecting mechanisms of collective migration | 000 | 2 | NIH | 5/19/2025 | $366,579 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61CA278445 | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | 000 | 3 | NIH | 3/21/2025 | $189,927 |
|
